Trial Interactive eClinical Solutions

Choose a faster way to launch and manage your global clinical trials, from site identification to close out.

Expedite Your Study
Doctor using a tablet

Scale your clinical operations with industry-leading technology and services.

Trial Interactive is designed to scale and grow with biotech and pharma companies. With eclinical solutions for every stage of the clinical trial lifecycle, our seamlessly connected platform streamlines and automates essential clinical processes across thousands of studies for sponsors, CROs, and sites around the world.

Speed, scalability, and peace of mind: get industry-leading technology and services to stay inspection-ready. Incorporate a platform that provides flexibility and adaptive trial master file processing.

  • AI Portal
    Industry-leading, AI-powered eTMF
  • Tablet
    Mobile eTMF (myTI)
  • Site Solutions
    Site Solutions
  • TMF 2
    TMF Services
  • Star with a tie
    TMF University
Learn More

Expedite site activation and improve oversight with remote site monitoring and mobile-first CTMS.

  • eLearning
    eFeasibility
  • Site Solutions
    Site Solutions
  • Study Start Up
    Study Start-Up
  • Remote Monitoring
    Remote Monitoring
  • CTMS
    CTMS
Learn More

Centralize your document collaboration and management across the clinical lifecycle from creation to indexing in the eTMF.

  • Third Party Integration
    Clinical Study Document Collaboration
  • Document Management
    General Document Management
  • Study Team Training
    Quality Documents and Training Management
Learn More

Reduce risk with remote site and study personnel training. Automatically index training records in the eTMF.

  • eLearning
    LMS and eLearning
  • Cog Certification
    QMS
  • Study Team Training
    Study Team Trainings
  • Human Resources
    Remote Investigator Meetings
Learn More

Controlling Complexity in Clinical Trials

Trial Interactive provides a practical, author-to-archive approach for streamlining clinical operations, reducing risk, and expediting time-to-market. Clinical professionals around the world consistently choose Trial Interactive as their preferred document management and oversight platform.

Reducing IT Burden on Small and Mid-Sized Pharma and Biotech

In this webinar, our Head of Product, Jay Smith, discusses the ways in which a complete and connected eClinical platform can help reduce the IT burden for small to mid-sized pharma and biotechs. Topics covered include regulation, compliance, validation, and change management.

Trusted by Life Sciences Organizations Big and Small

Join TransPerfect's community of over 1,000 life sciences organizations, including pharma, biotech, CROs, IRBs, and agencies.

20230124-lifesciences-resize-v3_0022_400x160px-hologic_logo.png
untitled_design_4.png
20230124-lifesciences-resize-v3_0016_400x160px-bayer_logo.png
20230124-lifesciences-resize-v3_0015_400x160px-merck_logo.png

Ready to Accelerate Timelines, Improve Quality, and Control Costs?

How did you hear about us?
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

News and Press Releases

Our industry experts have in-depth understanding of the challenges, requirements, and goals for life sciences organizations.

LifeSci Talks COA Series | Nothing Remains the Same: Why Measures Have to Evolve

In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with RJ Wirth, CEO and Consulting Psychometrician at Vector Psychometric Group, to talk about why the measures we rely on are living things rather than fixed artifacts. The two discuss why keeping a rigorous measure is often harder than building it in the first place, walk through why studies still run on out-of-date versions and translations, and reflect on ...

LifeSci Talks COA Series | Nothing Remains the Same: Why Measures Have to Evolve

When "How Does the Patient Feel?" Became a Regulatory Question

For decades, clinical trials were built around things you could measure with a machine: tumor shrinkage on a scan, laboratory values, and disease progression. These hard, objective endpoints were the backbone of drug approval. The patient's own account of how they felt,...

XTalks | eCOA: Has It Lived Up to the Promise? A Realistic Assessment for Today's Trials

Despite two decades of technological advancement, the debate between paper and electronic clinical outcome assessments (eCOA) remains unresolved. This webinar revisits the assumptions that continue to shape data collection strategies and examines whether current practice reflects ...

SSCPs Are Not Labeling: Compliant AI Processes for Reduced Cost & Turnaround

In this fireside chat, TransPerfect Medical Device's President Marc Miller sits down with Dr. Keith Morel, VP of Regulatory Compliance at Qserve, to unpack a critical question facing medical device manufacturers under MDR: can you reduce the translation review process for ...

Top 10 Pharma Company Overhauls Global COA Program,Cutting Costs by 33% and Errors to Near Zero

Inconsistent standards, stretched timelines, and limited visibility were straining a top 10 pharma company's COA program. Discover how TransPerfect Life Sciences' centralization strategy delivered 99.7% accuracy, 40% less PM oversight, and 33% cost savings across the ...

Four Years In: What the EU Clinical Trial Regulation Has (and Hasn't) Delivered

When the EU Clinical Trial Regulation (EU CTR No 536/2014) went live for new submissions on January 31, 2022, it promised to transform how clinical trials are authorized and conducted across Europe: a single submission, one decision, and harmonized oversight. Four years in,...

How to Make Your Academy Succeed at Global Scale—Lessons Learned on What Works and What Doesn’t

Most life sciences and MedTech companies launch a corporate academy with strong strategic intent, whether that’s executive sponsorship, a named platform, a dedicated budget, or a curriculum mapped to business goals. After launch, however, these same organizations all too often ...